Zobrazeno 1 - 10
of 76
pro vyhledávání: '"JA Knauf"'
Autor:
C Spourquet, O Delcorte, P Lemoine, N Dauguet, A Loriot, Y Achouri, M Hollmén, S Jalkanen, F Huaux, S Lucas, P Van Meerbeeck, JA Knauf, JA Fagin, C Dessy, M Mourad, P Henriet, D Tyteca, E Marbaix, CE Pierreux
Papillary thyroid carcinoma (PTC) is the most frequent histological subtype of thyroid cancers (TC), and BRAFV600E genetic alteration is found in 60% of this endocrine cancer. This oncogene is associated with poor prognosis, resistance to radioiodine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f7d32e2d6527513b67b6b4c04886975
https://doi.org/10.1101/2022.07.27.501733
https://doi.org/10.1101/2022.07.27.501733
Autor:
Krishnamoorthy GP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Glover AR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Untch BR; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sigcha-Coello N; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vukel D; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tiedje V; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berman K; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tamarapu PP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Acuña-Ruiz A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saqcena M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Boucai L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ghossein RA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knauf JA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Abdel-Wahab O; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bradley RK; Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Fagin JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.
Autor:
Landa I; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Thornton CEM; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Xu B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Haase J; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Krishnamoorthy GP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Hao J; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Knauf JA; Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, Massachusetts., Martínez P; Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain., Blasco MA; Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain., Ghossein R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Fagin JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2023 Nov 01; Vol. 21 (11), pp. 1163-1175.
Autor:
Boucai L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Saqcena M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Kuo F; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Grewal RK; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Socci N; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Knauf JA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Krishnamoorthy GP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Ryder M; Division of Endocrinology and Medical Oncology, Mayo Clinic, Rochester, Minnesota., Ho AL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Ghossein RA; Division of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Morris LGT; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Seshan V; Division of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Fagin JA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1620-1630.
Autor:
Wu SS; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Lamarre ED; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Yalamanchali A; Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Brauer PR; Case Western Reserve University School of Medicine, Cleveland, Ohio., Hong H; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio., Reddy CA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Yilmaz E; Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Woody N; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Ku JA; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Prendes B; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Burkey B; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio., Nasr C; Department of Internal Medicine, Division of Endocrinology, University of Arizona, Phoenix., Skugor M; Department of Endocrinology, Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, Ohio., Heiden K; Department of Endocrinology, Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, Ohio., Chute DJ; Department of Pathology, Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio., Knauf JA; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio., Campbell SR; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Koyfman SA; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Geiger JL; Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Scharpf J; Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio.
Publikováno v:
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2023 Apr 01; Vol. 149 (4), pp. 300-309.
Autor:
Landa I; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Thornton CE; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Xu B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Haase J; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Krishnamoorthy GP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hao J; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Knauf JA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA., Blasco MA; Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain., Ghossein R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fagin JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jan 24. Date of Electronic Publication: 2023 Jan 24.
Autor:
Garcia-Rendueles MER; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mariaelena.rodriguez@imdea.org.; IMDEA Food Institute, Madrid, Spain. mariaelena.rodriguez@imdea.org., Krishnamoorthy G; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Saqcena M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Acuña-Ruiz A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Revilla G; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knauf JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lester R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill-Cornell Medical College, New York, NY, USA., Ghossein RA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill-Cornell Medical College, New York, NY, USA., Fagin JA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. faginj@mskcc.org.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. faginj@mskcc.org.; Weill-Cornell Medical College, New York, NY, USA. faginj@mskcc.org.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Dec 07; Vol. 21 (1), pp. 213. Date of Electronic Publication: 2022 Dec 07.
Autor:
Spourquet C; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Delcorte O; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Lemoine P; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Dauguet N; CYTF Platform, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Loriot A; CBIO Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Achouri Y; Transgenesis Platform, Université Catholique de Louvain, 1200 Brussels, Belgium., Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, 20500 Turku, Finland., Jalkanen S; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, 20500 Turku, Finland., Huaux F; LTAP Unit, IREC, Université Catholique de Louvain, 1200 Brussels, Belgium., Lucas S; GECE Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium.; Walloon Excellence in Life Sciences and Biotechnology (WELBIO), 1300 Wavre, Belgium., Meerkeeck PV; GECE Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Knauf JA; Department of Otolaryngology Head & Neck Surgery in the Cleveland Clinic Lerner, College of Medicine of Case Western Reserve University, Cleveland, OH 44106, USA., Fagin JA; Department of Medicine and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Dessy C; FATH & MORF Unit, IREC, Université Catholique de Louvain, 1200 Brussels, Belgium., Mourad M; Surgery and Abdominal Transplantation Division, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium., Henriet P; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Tyteca D; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Marbaix E; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium., Pierreux CE; CELL Unit, de Duve Institute, Université Catholique de Louvain, 1200 Brussels, Belgium.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Sep 26; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 26.
Autor:
Ganly I; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Liu EM; Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kuo F; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Makarov V; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Dong Y; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Park J; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gong Y; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gorelick AN; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knauf JA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Benedetti E; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Tait-Mulder J; CRUK Beatson Institute, Glasgow, UK., Morris LGT; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fagin JA; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Intlekofer AM; Human Oncology and Pathology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Krumsiek J; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Gammage PA; CRUK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Ghossein R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Xu B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chan TA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA., Reznik E; Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Science advances [Sci Adv] 2022 Jun 24; Vol. 8 (25), pp. eabn9699. Date of Electronic Publication: 2022 Jun 22.
Autor:
Boucai L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Seshan V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Williams M; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA., Knauf JA; Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA., Saqcena M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ghossein RA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fagin JA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Mar 24; Vol. 107 (4), pp. 1030-1039.